M-CSF Increases Proliferation and Phagocytosis While Modulating Receptor and Transcription Factor Expression in Adult Human Microglia

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2013 Jul 20

PMID 23866312

Citations 53

Authors

Amy M Smith

Hannah M Gibbons

Robyn L Oldfield

Peter M Bergin

Edward W Mee

Maurice A Curtis

Richard L M Faull

Mike Dragunow

Affiliations

Soon will be listed here.

Abstract

Background: Microglia are the primary immune cells of the brain whose phenotype largely depends on their surrounding micro-environment. Microglia respond to a multitude of soluble molecules produced by a variety of brain cells. Macrophage colony-stimulating factor (M-CSF) is a cytokine found in the brain whose receptor is expressed by microglia. Previous studies suggest a critical role for M-CSF in brain development and normal functioning as well as in several disease processes involving neuroinflammation.

Methods: Using biopsy tissue from patients with intractable temporal epilepsy and autopsy tissue, we cultured primary adult human microglia to investigate their response to M-CSF. Mixed glial cultures were treated with 25 ng/ml M-CSF for 96 hours. Proliferation and phagocytosis assays, and high through-put immunocytochemistry, microscopy and image analysis were performed to investigate microglial phenotype and function.

Results: We found that the phenotype of primary adult human microglia was markedly changed following exposure to M-CSF. A greater number of microglia were present in the M-CSF- treated cultures as the percentage of proliferating (BrdU and Ki67-positive) microglia was greatly increased. A number of changes in protein expression occurred following M-CSF treatment, including increased transcription factors PU.1 and C/EBPβ, increased DAP12 adaptor protein, increased M-CSF receptor (CSF-1R) and IGF-1 receptor, and reduced HLA-DP, DQ, DR antigen presentation protein. Furthermore, a distinct morphological change was observed with elongation of microglial processes. These changes in phenotype were accompanied by a functional increase in phagocytosis of Aβ1-42 peptide.

Conclusions: We show here that the cytokine M-CSF dramatically influences the phenotype of adult human microglia. These results pave the way for future investigation of M-CSF-related targets for human therapeutic benefit.

Citing Articles

Assessing models for microglial development and fetal programming: a critical review.

Schepanski S, Ngoumou G, Buss C, Seifert G Front Immunol. 2025; 16:1538920.

PMID: 39944696 PMC: 11814449. DOI: 10.3389/fimmu.2025.1538920.

The Rise of Pluripotent Stem Cell-Derived Glia Models of Neuroinflammation.

Kala S, Strutz A, Katt M Neurol Int. 2025; 17(1).

PMID: 39852770 PMC: 11767680. DOI: 10.3390/neurolint17010006.

A bottom-up approach identifies the antipsychotic and antineoplastic trifluoperazine and the ribose derivative deoxytubercidin as novel microglial phagocytosis inhibitors.

Rodriguez-Iglesias N, Paris I, Valero J, Canas-Zabala L, Carretero A, Hatje K Glia. 2024; 73(2):330-351.

PMID: 39495090 PMC: 11662983. DOI: 10.1002/glia.24637.

Unraveling the links between circulating bioactive factors and epilepsy: A bidirectional Mendelian randomization study.

Wang W, Ma L, Liu M, Zhao Y, Ye W, Li X Medicine (Baltimore). 2024; 103(22):e38256.

PMID: 39259090 PMC: 11142776. DOI: 10.1097/MD.0000000000038256.

Macrophages and HLA-Class II Alleles in Multiple Sclerosis: Insights in Therapeutic Dynamics.

Prapas P, Anagnostouli M Int J Mol Sci. 2024; 25(13).

PMID: 39000461 PMC: 11242320. DOI: 10.3390/ijms25137354.

References

Boulanger L . Immune proteins in brain development and synaptic plasticity. Neuron. 2009; 64(1):93-109. DOI: 10.1016/j.neuron.2009.09.001. View

Takahashi K, Rochford C, Neumann H . Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med. 2005; 201(4):647-57. PMC: 2213053. DOI: 10.1084/jem.20041611. View

Feng R, Desbordes S, Xie H, Tillo E, Pixley F, Stanley E . PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci U S A. 2008; 105(16):6057-62. PMC: 2327209. DOI: 10.1073/pnas.0711961105. View

Gutsch R, Kandemir J, Pietsch D, Cappello C, Meyer J, Simanowski K . CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology. J Biol Chem. 2011; 286(26):22716-29. PMC: 3123039. DOI: 10.1074/jbc.M110.152538. View

Liu W, Brosnan C, Dickson D, Lee S . Macrophage colony-stimulating factor mediates astrocyte-induced microglial ramification in human fetal central nervous system culture. Am J Pathol. 1994; 145(1):48-53. PMC: 1887299. View

Weigelt K, Ernst W, Walczak Y, Ebert S, Loenhardt T, Klug M . Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation. J Leukoc Biol. 2007; 82(6):1564-74. DOI: 10.1189/jlb.0707447. View

Straccia M, Gresa-Arribas N, Dentesano G, Ejarque-Ortiz A, Tusell J, Serratosa J . Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein β. J Neuroinflammation. 2011; 8:156. PMC: 3223504. DOI: 10.1186/1742-2094-8-156. View

Lambert C, Ase A, Seguela P, Antel J . Distinct migratory and cytokine responses of human microglia and macrophages to ATP. Brain Behav Immun. 2010; 24(8):1241-8. DOI: 10.1016/j.bbi.2010.02.010. View

Rogers J, Lue L . Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem Int. 2001; 39(5-6):333-40. DOI: 10.1016/s0197-0186(01)00040-7. View

10.

Akiyama H, Nishimura T, Kondo H, Ikeda K, Hayashi Y, McGeer P . Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis. Brain Res. 1994; 639(1):171-4. DOI: 10.1016/0006-8993(94)91779-5. View

11.

Weigelt K, Carvalho L, Drexhage R, Wijkhuijs A, de Wit H, van Beveren N . TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors. Brain Behav Immun. 2011; 25(6):1162-9. DOI: 10.1016/j.bbi.2011.03.006. View

12.

Tissieres P, Araud T, Ochoda A, Drifte G, Dunn-Siegrist I, Pugin J . Cooperation between PU.1 and CAAT/enhancer-binding protein beta is necessary to induce the expression of the MD-2 gene. J Biol Chem. 2009; 284(39):26261-72. PMC: 2785314. DOI: 10.1074/jbc.M109.042580. View

13.

Otero K, Turnbull I, Poliani P, Vermi W, Cerutti E, Aoshi T . Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat Immunol. 2009; 10(7):734-43. PMC: 4004764. DOI: 10.1038/ni.1744. View

14.

Lentz M, Degaonkar M, Mohamed M, Kim H, Conant K, Halpern E . Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection. J Neurovirol. 2010; 16(5):368-76. PMC: 3164773. DOI: 10.3109/13550284.2010.513029. View

15.

Papavasiliou A, Mehler M, Mabie P, Marmur R, Qingbin S, Keating R . Paracrine regulation of colony-stimulating factor-1 in medulloblastoma: implications for pathogenesis and therapeutic interventions. Neurosurgery. 1997; 41(4):916-23. DOI: 10.1097/00006123-199710000-00028. View

16.

Streit W . Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 2006; 29(9):506-10. DOI: 10.1016/j.tins.2006.07.001. View

17.

Cortes-Canteli M, Luna-Medina R, Sanz-SanCristobal M, Alvarez-Barrientos A, Santos A, Perez-Castillo A . CCAAT/enhancer binding protein beta deficiency provides cerebral protection following excitotoxic injury. J Cell Sci. 2008; 121(Pt 8):1224-34. DOI: 10.1242/jcs.025031. View

18.

Davis M . Immunology taught by humans. Sci Transl Med. 2012; 4(117):117fs2. PMC: 3762495. DOI: 10.1126/scitranslmed.3003385. View

19.

Gow D, Sester D, Hume D . CSF-1, IGF-1, and the control of postnatal growth and development. J Leukoc Biol. 2010; 88(3):475-81. DOI: 10.1189/jlb.0310158. View

20.

Hart A, Wyttenbach A, Perry V, Teeling J . Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences. Brain Behav Immun. 2011; 26(5):754-65. PMC: 3381227. DOI: 10.1016/j.bbi.2011.11.006. View